# Certolizumab Pegol

## Cimzia inj 200mg/1mL

| 藥物代碼 | ICIM |
| :--- | :--- |
| 適應症 | NA |
| 副作用 | NA |
| 禁忌 | NA |
| 藥物保存方式 | 2-8°C冷藏,不可冷凍 |
| 用法用量 | Ankylosing spondylitis: Initial: 400 mg, repeat dose 2 and 4 weeks after initial dose; Maintenance: 200 mg every 2 weeks or 400 mg every 4 weeks. Axial spondyloarthritis: Initial: 400 mg, repeat dose 2 and 4 weeks after initial dose; Maintenance: 200 mg every 2 weeks or 400 mg every 4 weeks. Plaque psoriasis: 400 mg every other week. Note: For patients ?90 kg, an initial dose of 400 mg at weeks 0, 2, and 4 followed by 200 mg every other week thereafter may be considered. Psoriatic arthritis: Initial: 400 mg, repeat dose 2 and 4 weeks after initial dose; Maintenance: 200 mg every other week. May consider maintenance dose of 400 mg every 4 weeks. Rheumatoid arthritis: Initial: 400 mg, repeat dose 2 and 4 weeks after initial dose; Maintenance: 200 mg every other week. May consider maintenance dose of 400 mg every 4 weeks. May be administered alone or in combination with methotrexate. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest low risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | SC |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | 1.以皮下注射方式給藥。注射部位必須輪替，且不可注射於皮膚脆弱、瘀血、發紅或僵硬的部位。需要注射 400毫克時 \(皮下注射 200 毫克兩劑\)，應分別注射於大腿或腹部的不同部位。 2. 30 分鐘後可恢復室溫。不可使用其他回溫方式。若有氣泡為正常現象，在注射前不需移除氣泡。 3.不要搓揉注射部位。 |

